4//SEC Filing
Donato Peter 4
Accession 0001209191-19-029440
CIK 0001227636other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 6:33 PM ET
Size
20.8 KB
Accession
0001209191-19-029440
Insider Transaction Report
Form 4
Donato Peter
Vice President and CFO
Transactions
- Sale
Common Stock
2019-05-09$15.23/sh−20,469$311,743→ 32,166 total - Sale
Common Stock
2019-05-10$15.30/sh−706$10,802→ 29,582 total - Exercise/Conversion
Employee Stock Option (right to buy)
2019-05-09−6,905→ 9,667 totalExercise: $2.32Exp: 2027-07-19→ Common Stock (6,905 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2019-05-09−24,051→ 54,662 totalExercise: $3.19Exp: 2027-04-11→ Common Stock (24,051 underlying) - Exercise/Conversion
Common Stock
2019-05-09$2.32/sh+6,905$16,020→ 20,912 total - Exercise/Conversion
Common Stock
2019-05-09$4.64/sh+7,672$35,598→ 28,584 total - Exercise/Conversion
Common Stock
2019-05-09$3.19/sh+24,051$76,723→ 52,635 total - Sale
Common Stock
2019-05-09$15.67/sh−1,878$29,428→ 30,288 total - Exercise/Conversion
Employee Stock Option (right to buy)
2019-05-09−7,672→ 23,014 totalExercise: $4.64Exp: 2028-03-15→ Common Stock (7,672 underlying)
Footnotes (6)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.50 to $15.4925 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.50 to $15.935 inclusive.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.02 to $15.435 inclusive.
- [F4]Twenty-five percent (25%) of the shares subject to the option vested on July 20, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
- [F5]Twenty-five percent (25%) of the shares subject to the option vested on March 16, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
- [F6]Twenty-five percent (25%) of the shares subject to the option vested on April 10 ,2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
Documents
Issuer
Neuronetics, Inc.
CIK 0001227636
Entity typeother
Related Parties
1- filerCIK 0001408320
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 6:33 PM ET
- Size
- 20.8 KB